Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALT | Common Stock, par value $0.0001 | Options Exercise | $52K | +20K | +67.15% | $2.60 | 49.8K | Aug 19, 2024 | See Footnote | F1, F2 |
transaction | ALT | Common Stock, par value $0.0001 | Sale | -$54.2K | -7.83K | -15.72% | $6.93 | 42K | Aug 19, 2024 | See Footnote | F2, F3 |
transaction | ALT | Common Stock, par value $0.0001 | Options Exercise | $54.4K | +21.8K | +51.84% | $2.50 | 63.7K | Aug 19, 2024 | See Footnote | F1, F2 |
transaction | ALT | Common Stock, par value $0.0001 | Sale | -$56.3K | -8.18K | -12.85% | $6.88 | 55.5K | Aug 19, 2024 | See Footnote | F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALT | Stock Options (option to buy) | Options Exercise | $0 | -20K | -100% | $0.00 | 0 | Aug 19, 2024 | Common Stock, par value $0.0001 | 20K | $2.60 | Direct | F4 |
transaction | ALT | Stock Options (option to buy) | Options Exercise | $0 | -21.8K | -83.33% | $0.00 | 4.35K | Aug 19, 2024 | Common Stock, par value $0.0001 | 21.8K | $2.50 | Direct | F5 |
Id | Content |
---|---|
F1 | Shares received upon exercise were immediately transferred to Pacific Biopharma Associates, LLC. |
F2 | Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President. |
F3 | This sale represents shares sold to cover the exercise price. |
F4 | The shares underlying the option became vested and exercisable in two equal installments on February 28, 2019 and August 30, 2019, in each case, generally subject to the reporting person's continued service through the applicable vesting date. |
F5 | The shares underlying the option became vested and exercisable in substantially equal monthly installments over the 12 months following September 28, 2023, subject to the reporting person's continued service through the applicable vesting date. |
Exhibit 24 - Power of Attorney